ylliX - Online Advertising Network
Press Release

U.S. Patent Office Completes Review of Medtronic Patents, Rejects More Axonics Challenges

U.S. Patent Office Completes Review of Medtronic Patents, Rejects More Axonics Challenges

<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>

DUBLIN, Sept. 22, 2021 /PRNewswire/ — Medtronic (NYSE:MDT), the global leader in medical technology, today announced that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has affirmed an additional three patents in a dispute with Axonics over intellectual property for its sacral neuromodulation (SNM) device family, the InterStim™ systems.

...read full article on PRNewsWire

ylliX - Online Advertising Network